List of Excipients in API decitabine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing decitabine
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Otsuka America Pharmaceutical Inc | DACOGEN | decitabine | 59148-046 | MONOBASIC POTASSIUM PHOSPHATE | |
Otsuka America Pharmaceutical Inc | DACOGEN | decitabine | 59148-046 | SODIUM HYDROXIDE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing decitabine
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Hikma Pharmaceuticals USA Inc | decitabine | 0143-9385 | HYDROCHLORIC ACID |
Hikma Pharmaceuticals USA Inc | decitabine | 0143-9385 | POTASSIUM PHOSPHATE, MONOBASIC |
Hikma Pharmaceuticals USA Inc | decitabine | 0143-9385 | SODIUM HYDROXIDE |
Sandoz Inc | decitabine | 0781-3296 | POTASSIUM PHOSPHATE, MONOBASIC |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for decitabine
Excipient focus: HYDROCHLORIC ACID
decitabine drug variants containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | decitabine | 0143-9385 |
Sagent Pharmaceuticals | decitabine | 25021-219 |
Camber Pharmaceuticals Inc | decitabine | 31722-304 |
Eugia US LLC | decitabine | 55150-376 |
>Company | >Ingredient | >NDC |
decitabine drug variants not containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Sandoz Inc | decitabine | 0781-3296 |
NorthStar RxLLC | decitabine | 16714-749 |
Northstar Rx LLC | decitabine | 16714-928 |
Accord Healthcare Inc | decitabine | 16729-224 |
>Company | >Ingredient | >NDC |
Excipient focus: MONOBASIC POTASSIUM PHOSPHATE
decitabine drug variants containing MONOBASIC POTASSIUM PHOSPHATE
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | decitabine | 31722-304 |
Otsuka America Pharmaceutical Inc | decitabine | 59148-046 |
Cipla USA Inc | decitabine | 69097-905 |
Athenex Pharmaceutical Division LLC | decitabine | 70860-219 |
>Company | >Ingredient | >NDC |
decitabine drug variants not containing MONOBASIC POTASSIUM PHOSPHATE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | decitabine | 0143-9385 |
Sandoz Inc | decitabine | 0781-3296 |
NorthStar RxLLC | decitabine | 16714-749 |
Northstar Rx LLC | decitabine | 16714-928 |
>Company | >Ingredient | >NDC |
Excipient focus: NITROGEN
decitabine drug variants containing NITROGEN
Company | Ingredient | NDC |
---|---|---|
NorthStar RxLLC | decitabine | 16714-749 |
>Company | >Ingredient | >NDC |
decitabine drug variants not containing NITROGEN
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | decitabine | 0143-9385 |
Sandoz Inc | decitabine | 0781-3296 |
Northstar Rx LLC | decitabine | 16714-928 |
Accord Healthcare Inc | decitabine | 16729-224 |
>Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM PHOSPHATE, MONOBASIC
decitabine drug variants containing POTASSIUM PHOSPHATE, MONOBASIC
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | decitabine | 0143-9385 |
Sandoz Inc | decitabine | 0781-3296 |
NorthStar RxLLC | decitabine | 16714-749 |
Northstar Rx LLC | decitabine | 16714-928 |
>Company | >Ingredient | >NDC |
decitabine drug variants not containing POTASSIUM PHOSPHATE, MONOBASIC
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | decitabine | 31722-304 |
Otsuka America Pharmaceutical Inc | decitabine | 59148-046 |
Cipla USA Inc | decitabine | 69097-905 |
Athenex Pharmaceutical Division LLC | decitabine | 70860-219 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
decitabine drug variants containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | decitabine | 0143-9385 |
Sandoz Inc | decitabine | 0781-3296 |
NorthStar RxLLC | decitabine | 16714-749 |
Northstar Rx LLC | decitabine | 16714-928 |
>Company | >Ingredient | >NDC |
decitabine drug variants not containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
BluePoint Laboratories | decitabine | 68001-347 |
Cipla USA Inc | decitabine | 69097-285 |
>Company | >Ingredient | >NDC |
Excipient focus: WATER
decitabine drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Sandoz Inc | decitabine | 0781-3296 |
NorthStar RxLLC | decitabine | 16714-749 |
Sagent Pharmaceuticals | decitabine | 25021-231 |
Gland Pharma Limited | decitabine | 68083-528 |
>Company | >Ingredient | >NDC |
decitabine drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
Hikma Pharmaceuticals USA Inc | decitabine | 0143-9385 |
Northstar Rx LLC | decitabine | 16714-928 |
Accord Healthcare Inc | decitabine | 16729-224 |
Sagent Pharmaceuticals | decitabine | 25021-219 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.